Skip to content
2000
Volume 6, Issue 3
  • ISSN: 1573-4013
  • E-ISSN: 2212-3881

Abstract

Age-related macular degeneration (AMD) is a progressive eye disease that attacks the macula of the eye, the area responsible for the sharpest central vision, and affects 5% of people aged 65 and older. Current treatment strategies are of limited benefit and only to a minority of people with specific forms of the disease, thus prevention of macular degeneration at an early stage may be a key factor for both managing and reducing the public health burden of this condition. Due to their antioxidant properties and their location in the macula lutea (and therefore also referred to as macular pigments), lutein and zeaxanthin are believed to play a key role in the prevention of AMD by aiding in the filtration of damaging blue light and sunlight. This review will assess the evidence about the relationship of lutein and zeaxanthin to the prevention of AMD.

Loading

Article metrics loading...

/content/journals/cnf/10.2174/157340110792389118
2010-08-01
2025-06-19
Loading full text...

Full text loading...

/content/journals/cnf/10.2174/157340110792389118
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test